Other equities research analysts have also issued research reports about the stock. Hauck & Aufhaeuser set a €45.00 ($52.33) price objective on shares of Fielmann and gave the stock a sell rating in a research note on Friday, August 31st. Commerzbank set a €65.00 ($75.58) price objective on shares of Fielmann and gave the stock a neutral rating in a research note on Thursday, August 30th. HSBC set a €57.00 ($66.28) target price on shares of Fielmann and gave the stock a neutral rating in a report on Monday, August 13th. Warburg Research set a €61.00 ($70.93) target price on shares of Fielmann and gave the stock a neutral rating in a report on Thursday, August 30th. Finally, Kepler Capital Markets set a €50.50 ($58.72) target price on shares of Fielmann and gave the stock a sell rating in a report on Tuesday, October 30th. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have issued a buy rating to the company. Fielmann has an average rating of Hold and a consensus price target of €59.96 ($69.72).
FRA:FIE traded up €1.40 ($1.63) during mid-day trading on Friday, hitting €56.70 ($65.93). 79,592 shares of the company’s stock were exchanged. Fielmann has a one year low of €65.50 ($76.16) and a one year high of €77.50 ($90.12).
Fielmann Company Profile
Fielmann Aktiengesellschaft invests in and operates optical and hearing aid businesses in Germany, Switzerland, Austria, and internationally. The company designs, manufactures, distributes, and retails visual aids and other optical products, including glasses, frames, lenses, sunglasses, contact lenses, and related articles and accessories, as well as hearing aids and accessories.
Read More: Understanding Relative Strength Index
Receive News & Ratings for Fielmann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fielmann and related companies with MarketBeat.com's FREE daily email newsletter.